Pathophysiologic basis of contrast enhancement in breast tumors
While the diagnostic benefits of gadolinium (Gd)‐chelate contrast agents are firmly established in magnetic resonance imaging (MRI) of tumors, the pathophysiologic basis of the enhancement observed and its histopathologic correlate remained vague.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
01 October 1999
|
| In: |
Journal of magnetic resonance imaging
Year: 1999, Jahrgang: 10, Heft: 3, Pages: 260-266 |
| ISSN: | 1522-2586 |
| DOI: | 10.1002/(SICI)1522-2586(199909)10:3<260::AID-JMRI6>3.0.CO;2-7 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/(SICI)1522-2586(199909)10:3<260::AID-JMRI6>3.0.CO;2-7 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/10.1002/(SICI)1522-2586(199909)10:3<260::AID-JMRI6>3.0.CO;2-7 |
| Verfasserangaben: | M.V. Knopp, E. Weiss, H.P. Sinn, J. Mattern, H. Junkermann, J. Radeleff, A. Magener, G. Brix, S. Delorme, I. Zuna, and G. van Kaick |
| Zusammenfassung: | While the diagnostic benefits of gadolinium (Gd)‐chelate contrast agents are firmly established in magnetic resonance imaging (MRI) of tumors, the pathophysiologic basis of the enhancement observed and its histopathologic correlate remained vague. |
|---|---|
| Beschreibung: | Gesehen am 18.02.2021 |
| Beschreibung: | Online Resource |
| ISSN: | 1522-2586 |
| DOI: | 10.1002/(SICI)1522-2586(199909)10:3<260::AID-JMRI6>3.0.CO;2-7 |